Business
The ASX health giant riding COVID’s second wave – The Australian Financial Review
Fisher & Paykel Healthcare’s humidifiers have become vital to the treatment of COVID-19 cases. But investors are starting to look beyond the virus.
Operating revenue surged 59 per cent to $NZ910.2 million ($862.7 million) as earnings rose 86 per cent to $NZ225.5 million ($213.7 million).
Typically, the group has derived about 60 per cent of its revenue from selling hardware and associated consumables into hospitals, with the other 40 per cent from selling products for home care, particularly in the treatment of sleep apnoea.
But in the September half, 75 per cent of revenue came from the hospital side of the business. Hospital hardware sales…
-
Noosa News23 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
Noosa News24 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
General22 hours agoTyler Wright soaks up Bells Beach return as poor conditions at Rip Curl Pro sees men’s opening round called off
-
General23 hours agoSowing doubt in Dutton’s Dickson • Inside Story